Inogen Gross Margin 2012-2024 | INGN
Current and historical gross margin for Inogen (INGN) over the last 10 years. The current gross profit margin for Inogen as of December 31, 2024 is %.
| Inogen Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.34B | $0.15B | 45.83% |
| 2024-09-30 | $0.33B | $0.15B | 43.98% |
| 2024-06-30 | $0.33B | $0.14B | 42.51% |
| 2024-03-31 | $0.32B | $0.13B | 40.37% |
| 2023-12-31 | $0.32B | $0.13B | 40.19% |
| 2023-09-30 | $0.33B | $0.13B | 39.02% |
| 2023-06-30 | $0.35B | $0.14B | 39.26% |
| 2023-03-31 | $0.37B | $0.15B | 40.49% |
| 2022-12-31 | $0.38B | $0.15B | 40.69% |
| 2022-09-30 | $0.36B | $0.16B | 44.78% |
| 2022-06-30 | $0.35B | $0.17B | 47.73% |
| 2022-03-31 | $0.35B | $0.17B | 49.00% |
| 2021-12-31 | $0.36B | $0.18B | 49.44% |
| 2021-09-30 | $0.36B | $0.17B | 48.31% |
| 2021-06-30 | $0.34B | $0.16B | 46.59% |
| 2021-03-31 | $0.31B | $0.14B | 45.60% |
| 2020-12-31 | $0.31B | $0.14B | 44.81% |
| 2020-09-30 | $0.31B | $0.14B | 44.09% |
| 2020-06-30 | $0.33B | $0.15B | 44.71% |
| 2020-03-31 | $0.36B | $0.17B | 45.83% |
| 2019-12-31 | $0.36B | $0.17B | 47.24% |
| 2019-09-30 | $0.37B | $0.18B | 48.92% |
| 2019-06-30 | $0.37B | $0.19B | 50.13% |
| 2019-03-31 | $0.37B | $0.19B | 50.14% |
| 2018-12-31 | $0.36B | $0.18B | 50.00% |
| 2018-09-30 | $0.34B | $0.17B | 49.55% |
| 2018-06-30 | $0.31B | $0.15B | 48.54% |
| 2018-03-31 | $0.28B | $0.13B | 48.55% |
| 2017-12-31 | $0.25B | $0.12B | 48.80% |
| 2017-09-30 | $0.24B | $0.12B | 48.95% |
| 2017-06-30 | $0.22B | $0.11B | 48.65% |
| 2017-03-31 | $0.21B | $0.10B | 47.89% |
| 2016-12-31 | $0.20B | $0.10B | 47.78% |
| 2016-09-30 | $0.19B | $0.09B | 47.92% |
| 2016-06-30 | $0.18B | $0.09B | 48.04% |
| 2016-03-31 | $0.17B | $0.08B | 48.21% |
| 2015-12-31 | $0.16B | $0.08B | 47.80% |
| 2015-09-30 | $0.15B | $0.07B | 47.30% |
| 2015-06-30 | $0.14B | $0.07B | 48.53% |
| 2015-03-31 | $0.12B | $0.06B | 49.18% |
| 2014-12-31 | $0.11B | $0.06B | 50.00% |
| 2014-09-30 | $0.10B | $0.05B | 50.49% |
| 2014-06-30 | $0.09B | $0.05B | 50.00% |
| 2014-03-31 | $0.08B | $0.04B | 51.19% |
| 2013-12-31 | $0.08B | $0.04B | 51.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.190B | $0.336B |
| Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. | |||